Palvella Therapeutics (PVLA) Net Margin Growth (1y) (2015 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3,082.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,120.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -653.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,849.00 |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -436,820.00 |
| Sep 30, 2023 | 455,056.00 |
| Jun 30, 2023 | 36,446.00 |
| Mar 31, 2023 | -71,486.00 |
| Sep 30, 2022 | -393,986.00 |
| Jun 30, 2022 | 30,803.00 |
| Mar 31, 2022 | -2,900.00 |
| Dec 31, 2021 | 43,914.00 |
| Sep 30, 2021 | -24,258.00 |
| Jun 30, 2021 | -61,952.00 |
| Mar 31, 2021 | -1,222.00 |
| Dec 31, 2020 | -63,556.00 |
| Sep 30, 2020 | -42,329.00 |
| Jun 30, 2020 | 18,027.00 |
| Mar 31, 2020 | 9,443.00 |
| Dec 31, 2019 | 192,177.00 |
| Sep 30, 2019 | 5,660.00 |
| Jun 30, 2019 | -21,878.00 |
| Mar 31, 2019 | 8,877.00 |
| Dec 31, 2018 | -198,827.00 |
| Sep 30, 2018 | 10,602.00 |
| Jun 30, 2018 | 54,252.00 |
| Mar 31, 2018 | 38,536.00 |
| Dec 31, 2017 | 27,587.00 |
| Sep 30, 2017 | 60,956.00 |
| Jun 30, 2017 | 412.00 |
| Mar 31, 2017 | -26,145.00 |
| Dec 31, 2016 | -92,013.00 |
| Sep 30, 2016 | 15,669.00 |
| Jun 30, 2016 | 165,452.00 |
| Mar 31, 2016 | 136,860.00 |
| Sep 30, 2015 | 985,377.00 |
| Jun 30, 2015 | -179,018.00 |